You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
泰林生物(300813.SZ):擬推2022年限制性股票激勵計劃
格隆匯 04-18 18:10

格隆匯4月18日丨泰林生物(300813.SZ)公佈2022年限制性股票激勵計劃(草案),該激勵計劃擬向激勵對象授予的限制性股票數量總計為103.94萬股,約佔激勵計劃草案公吿時公司股本總額5,197.00萬股的2.00%。

其中,首次授予限制性股票93.90萬股,約佔激勵計劃草案公吿時公司股本總額的1.81%,佔本次授予權益總額的90.34%;預留10.04萬股,約佔激勵計劃草案公吿時公司股本總額的0.19%,佔本次授予權益總額的9.66%。

激勵計劃首次授予的限制性股票的授予價格為 41.66元/股。預留限制性股票的授予價格與首次授予限制性股票的授予價格一致。

激勵計劃擬首次授予的激勵對象總人數為87人,包括公司公吿激勵計劃時在公司(含子公司)任職的董事、高級管理人員、中層管理人員和核心骨幹以及公司董事會認為需要進行激勵的其他員工。

激勵計劃有效期自限制性股票首次授予之日起至激勵對象獲授的限制性股票全部歸屬或作廢失效之日止,最長不超過60個月。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account